Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
December 1, 2023
Primary Completion Date
May 30, 2024
Study Completion Date
May 30, 2024
Conditions
Prostate Cancer
Trial Locations (1)
200000
Fudan University Shanghai Cancer Center, Shanghai
All Listed Sponsors
lead
Fudan University
OTHER
NCT06484127 - Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study | Biotech Hunter | Biotech Hunter